Related Experiment Video
Updated: Feb 28, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Current progress in antivascular tumor therapy
Yi-Ju Ho1, Tzu-Chia Wang1, Ching-Hsiang Fan1
1Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan.
Abstract:
The tumor vasculature transports oxygen, nutrients and drugs for crucial roles in tumor therapy. Antivascular therapy directly targets existing tumor vessels to reduce blood perfusion and then inhibit tumor growth. Vascular disrupting agents and ultrasound-stimulated microbubble destruction use chemical toxicity and physical effect, respectively, to damage vascular endothelial cells for antivascular therapy. Moreover, antivascular therapy can break vessel wall barriers and change the tumor microenvironment to compensate for the limitations of conventional chemotherapy or radiotherapy. This review presents current progress and an overview of antivascular therapy, which can inform the development and application in cancer research.
Insights
Antivascular therapy targets tumor blood vessels to inhibit cancer growth. This approach enhances conventional treatments by altering the tumor microenvironment, offering new avenues for cancer research.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Therapy
Background:
- Tumor vasculature is essential for supplying oxygen, nutrients, and drugs.
- Antivascular therapy directly targets tumor vessels to impede tumor growth.
- This strategy can overcome limitations of traditional cancer treatments.
Purpose of the Study:
- To review current progress in antivascular therapy.
- To provide an overview of antivascular therapeutic strategies.
- To inform future development and application of antivascular therapy in cancer research.
Main Methods:
- Review of existing literature on antivascular therapies.
- Analysis of mechanisms of action for vascular disrupting agents and ultrasound-stimulated microbubble destruction.
- Examination of how antivascular therapy modifies the tumor microenvironment.
Main Results:
- Antivascular therapy reduces tumor blood perfusion by damaging vascular endothelial cells.
- Chemical toxicity (vascular disrupting agents) and physical effects (ultrasound-stimulated microbubble destruction) are key mechanisms.
- Antivascular therapy can break down vessel wall barriers, improving drug delivery and efficacy.
Conclusions:
- Antivascular therapy represents a promising strategy in cancer treatment.
- This approach can be combined with conventional chemotherapy or radiotherapy for enhanced outcomes.
- Further research and development are needed to optimize antivascular therapy applications.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
12:09A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
Related Concept Videos
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...